Evidence map›Paper›PMID 32424232›Full record

ReviewGene therapy2020

Recent development of AAV-based gene therapies for inner ear disorders.

Yiyang Lan, Yong Tao, Yunfeng Wang, Junzi Ke, Qiuxiang Yang, Xiaoyi Liu, Bing Su, Yiling Wu, Chao-Po Lin, Guisheng Zhong

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Gene therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. AAVR Expression is Essential for AAV Vector Transduction in Sensory Hair Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. [Phenotypic and pathogenic variant analysis of an X-linked dominant inherited non-syndromic hearing loss pedigree].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Article
  4. Article
  5. AAV-mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Gene Therapy to the Retina and the Cochlea.Frontiers in neuroscience · 2021
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yiyang LaniHuman Institute, ShanghaiTech University, Shanghai, 201210, China.
Yong TaoDepartment of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China.
Yunfeng WangENT institute and Otorhinolaryngology Department of Eye & ENT Hospital, NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, 200031, China.
Junzi KeiHuman Institute, ShanghaiTech University, Shanghai, 201210, China.
Qiuxiang YangiHuman Institute, ShanghaiTech University, Shanghai, 201210, China.
Xiaoyi LiuiHuman Institute, ShanghaiTech University, Shanghai, 201210, China.
Bing SuiHuman Institute, ShanghaiTech University, Shanghai, 201210, China.
Yiling WuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Chao-Po LinSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Guisheng ZhongiHuman Institute, ShanghaiTech University, Shanghai, 201210, China. zhongsh@shanghaitech.edu.cn.
ShanghaiTech University · CNEye & ENT Hospital of Fudan University · CNShanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene therapy for auditory diseases is gradually maturing. Recent progress in gene therapy treatments for genetic and acquired hearing loss has demonstrated the feasibility in animal models. However, a number of hurdles, such as lack of safe viral vector with high efficiency and specificity, robust deafness large animal models, translating animal studies to clinic etc., still remain to be solved. It is necessary to overcome these challenges in order to effectively recover auditory function in human patients. Here, we review the progress made in our group, especially our efforts to make more effective and cell type-specific viral vectors for targeting cochlea cells.

Indexed as

DependovirusGenetic TherapyHearing LossAnimalsCochleaGenetic VectorsHumans

Identifiers

PMID32424232
PMCPMC7445886
OpenAlexW3025746704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.